Curcumin/Turmeric Supplementation on Glycemic Control in Adults With Prediabetes and Type 2 Diabetes: A Systematic Review and Dose–Response Meta‐Analysis
Food Science & Nutrition · 2026-04 · 14 (4)
DOI: 10.1002/fsn3.71748 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Food Science & Nutrition, online erschienen am 16.04.2026. Verfasst von Hossein Bahari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Curcumin and turmeric have demonstrated potential hypoglycemic properties in preclinical studies, but findings from human randomized controlled trials (RCTs) in prediabetes and type 2 diabetes (T2D) are inconsistent. PubMed, Scopus, and Web of Science ISI databases were comprehensively searched until August 2025 (25/08/2025) to find eligible RCTs. Overall effect sizes were estimated based on the random‐effect models and presented as weighted mean differences (WMD) with 95% confidence intervals (95% CI). All analyses were performed using version 17.0 (Stata Corp., College Station, TX, USA). Thirty‐four eligible RCTs (39 treatment arms) were included in this review. Curcumin/turmeric supplementation significantly reduced fasting blood glucose (FBG) (WMD = −10.15 mg/dL; 95% CI: −12.59, −7.72), hemoglobin A1c (HbA1c) (WMD = −0.32%; 95% CI: −0.43, −0.21), fasting insulin (WMD = −0.69 μU/ml; 95% CI: −1.27, −0.12), homeostatic model assessment of insulin resistance (HOMA‐IR) (WMD = −0.46; 95% CI: −0.60, −0.32), and oral glucose tolerance test (OGTT) (WMD = −11.53 mg/dL; 95% CI: −22.68, −0.44) compared to control groups. However, no significant alteration in homeostatic model assessment of β ‐cell function (HOMA‐B) levels was detected, followed by Curcumin or turmeric supplementation in comparison to the control groups. Subgroup analyses indicated that efficacy was modified by health status (T2D vs. prediabetes), dosage (≥ 1 g/day more effective), and formulation. This meta‐analysis revealed that curcumin/turmeric supplementation may improve glycemic control in individuals with prediabetes or T2D. Despite positive findings, significant heterogeneity across studies necessitates caution. Furthermore, future high‐quality RCTs are required to reach a firm conclusion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nutrition, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran.
- Student Research Committee Mashhad University of Medical Sciences Mashhad Iran.
- Student Research Committee Shiraz University of Medical Sciences Shiraz Iran.
- Rajaei Cardiovascular Medical and Research Center Iran University of Medical Sciences Tehran Iran.
ORCID-Profile: Hossein Bahari, Mostafa Shahraki Jazinaki, Haniyeh Golafrouz
Zitieren
APA
Bahari, H., Jazinaki, M. S., Asadi, Z., & Golafrouz, H. (2026). Curcumin/Turmeric Supplementation on Glycemic Control in Adults With Prediabetes and Type 2 Diabetes: A Systematic Review and Dose–Response Meta‐Analysis. Food Science & Nutrition, 14(4). https://doi.org/10.1002/fsn3.71748
Vancouver
Bahari H, Jazinaki MS, Asadi Z, Golafrouz H. Curcumin/Turmeric Supplementation on Glycemic Control in Adults With Prediabetes and Type 2 Diabetes: A Systematic Review and Dose–Response Meta‐Analysis. Food Science & Nutrition. 2026;14(4). doi:10.1002/fsn3.71748
BibTeX
@article{Bahari2026,
author = {Bahari, Hossein and Jazinaki, Mostafa Shahraki and Asadi, Zahra and Golafrouz, Haniyeh},
title = {Curcumin/Turmeric Supplementation on Glycemic Control in Adults With Prediabetes and Type 2 Diabetes: A Systematic Review and Dose–Response Meta‐Analysis},
journal = {Food Science & Nutrition},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/fsn3.71748}
}
EUVIMED